Found: 5
Select item for more details and to access through your institution.
Clinical Features and Immunogenetic Risk Factors Associated With Additional Autoantibodies in Anti‐Transcriptional Intermediary Factor 1γ Juvenile‐Onset Dermatomyositis.
- Published in:
- Arthritis & Rheumatology, 2024, v. 76, n. 4, p. 631, doi. 10.1002/art.42768
- By:
- Publication type:
- Article
Serum S100A8/A9 and S100A12 Levels in Children With Polyarticular Forms of Juvenile Idiopathic Arthritis: Relationship to Maintenance of Clinically Inactive Disease During Anti–Tumor Necrosis Factor Therapy and Occurrence of Disease Flare After Discontinuation of Therapy
- Published in:
- Arthritis & Rheumatology, 2019, v. 71, n. 3, p. 451, doi. 10.1002/art.40727
- By:
- Publication type:
- Article
Risk, Timing, and Predictors of Disease Flare After Discontinuation of Anti–Tumor Necrosis Factor Therapy in Children With Polyarticular Forms of Juvenile Idiopathic Arthritis With Clinically Inactive Disease.
- Published in:
- Arthritis & Rheumatology, 2018, v. 70, n. 9, p. 1508, doi. 10.1002/art.40509
- By:
- Publication type:
- Article
High Levels of DEK Autoantibodies in Sera of Patients With Polyarticular Juvenile Idiopathic Arthritis and With Early Disease Flares Following Cessation of Anti–Tumor Necrosis Factor Therapy.
- Published in:
- Arthritis & Rheumatology, 2018, v. 70, n. 4, p. 594, doi. 10.1002/art.40404
- By:
- Publication type:
- Article
Age and fecal microbial strain-specific differences in patients with spondyloarthritis.
- Published in:
- Arthritis Research & Therapy, 2018, v. 20, p. 1, doi. 10.1186/s13075-018-1510-6
- By:
- Publication type:
- Article